Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors-Reference-Cited by-同舟云学术

Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors

Published:2020-05 Issue:5 Volume:19 Page:102509
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Bodio Caterina,Grossi Claudia,Pregnolato Francesca,Favalli Ennio Giulio,Biggioggero Martina,Marchesoni Antonio,Murgo Antonella,Filippini Matteo,Migliorini Paola,Caporali Roberto,Pellerito Raffaele,Ciccia Francesco,Sarzi-Puttini Piercarlo,Perosa Federico,Paolazzi Giuseppe,Hollan Ivana,Bendtzen Klaus,Meroni Pier Luigi,Borghi Maria Orietta

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

2. The giants (biologicals) against the pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis;Favalli;Autoimmun Rev,2020

3. Immunogenicity and autoimmunity during anti-TNF therapy;Atzeni;Autoimmun Rev,2013

4. The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis;Pecoraro;Autoimmun Rev,2017

5. Immunogenicity and loss of response to TNF inhibitors: Implications for rheumatoid arthritis treatment;Kalden;Nat Rev Rheumatol,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

2. Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview;Expert Opinion on Drug Metabolism & Toxicology;2023-10-25

3. Levels of antibodies to adalimumab in children with juvenile idiopathic arthritis at different stages of treatment;CHILD`S HEALTH;2023-03-25

4. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy;Journal of Clinical Medicine;2023-02-17

5. Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis;Expert Review of Molecular Diagnostics;2022-10-03